Perceptive Informatics Enhances its eClinical Platform with IBM Technologies

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that it is bringing further advancements to its eClinical platform. Perceptive has incorporated IBM's WebSphere® portal and Tivoli® Access Manager into its eClinical platform, which provides support for its eClinical Suite.

Powered by foundational technologies that enable applications within its eClinical Suite, Perceptive's eClinical platform incorporates reporting, integration, and identity management solutions, among others. The platform technologies from IBM allow Perceptive to support more extensive interoperability between its systems and facilitate a single entry point for users. The technologies also provide support for Perceptive's eClinical solutions offered as Software-as-a-Service (SaaS) applications, which are developed to be hosted by Perceptive.

"As the number of technologies used in clinical trials increases, Perceptive is committed to expanding our robust and flexible enterprise platform to meet customer demand for innovative, sophisticated, and easily accessible eClinical solutions," said Nicholas Richards, Vice President, Product Development, Perceptive Informatics. "The solutions Perceptive is developing are fundamentally changing the way technology is accessed and used in clinical trials. Our customers can benefit from foundational technologies that further enhance the capabilities of our eClinical Suite to bring more efficiency to biopharmaceutical development."

IBM's WebSphere portal framework enhances the Perceptive Portal enterprise solution, which provides secure, centralized access to clinical trial documentation and training materials as well as a collaboration area to develop related materials. The portal's reporting engine displays consolidated trial metrics, allowing study performance to be easily tracked using data drawn from multiple sources. Perceptive has incorporated IBM's Tivoli Access Manager to improve single sign-on functionality. Designed to streamline workflow, this advancement eliminates the need for multiple user names and passwords by providing access to various systems with one set of credentials.

The eClinical Suite from Perceptive Informatics provides advanced integration and interoperability among systems, including the IMPACT® Clinical Trial Management System (CTMS), the DataLabs® EDC solution, and the ClinPhone® Randomization and Trial Supply Management (RTSM) technologies. The suite supports real-time data interchange and enables diverse applications to work synergistically. For more information about Perceptive's eClinical Suite visit: www.perceptive.com/Solutions/eClinical-Suite.

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.